[Federal Register: November 22, 2004 (Volume 69, Number 224)]
[Notices]               
[Page 67963]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22no04-121]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 28, 2004, Orasure 
Technologies, Inc., Lehigh University, Seeley G. Mudd-Building 6, 
Bethlehem, Pennsylvania 18015, made application by renewal to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Alphamethadol (9605).......................  I
Benzoylecgonine (9180).....................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk to manufacture other controlled substances.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative, 
Office of Liaison and Policy (ODLR) and must be filed no later than 
January 21, 2005.

    Dated: November 8, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-25769 Filed 11-19-04; 8:45 am]

BILLING CODE 4410-09-P